MedPath

Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients

Not Applicable
Conditions
prostate cancer
Registration Number
JPRN-UMIN000017825
Lead Sponsor
Department of Urology, Keio university, school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

prostate cancer not eligible for I125 seed implant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
voiding parameters
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath